Search Results "#VANFLYTA"

Blogs

arrow_forward View More Results
Daiichi Sankyo’s FLT3 Inhibitor VANFLYTA Approved by the FDA in the US.
Posted by Mansi Jain on August 01 at 10:36 AM   public
On July 20, 2023, Daiichi Sankyo Company, Limited – a global pharmaceutical giant, announced that for the treatment of adults with newly diagnosed FLT3 - ITD Positive Acute Myeloid Leukemia...
arrow_forward